Ipsen bolsters executive leadership with two new recruits
pharmafile | April 12, 2018 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | appointment, ipsen, pharma
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will join the company as Executive Vice President, Chief Business Officer, while Régis Mulot joins as Executive Vice President, Chief Human Resources Officer.
Previously serving at Axcella Health as Executive Vice-President, Chief Strategy and Corporate Development Office, Dr Magovčević-Liebisch brings two decades of senior biopharma management experience to the French firm, specialising in corporate partnering, M&A, pipeline and product portfolio development, legal and IP strategy.
Earlier in her career, she worked with Teva from 2013 to 2017 as its Senior Vice President and Head of Global Business Development, leading the licensing and acquisition of drug candidates, commercial products and companies, among other responsibilities. Prior to this, she also served at Dyax, which was later acquired by Shire in 2015, from 2001 in a range of roles including Executive Vice-President and Chief Operating Officer.
Mulot arrives at Ipsen from retail firm Staples, leaving his previous role as Executive Vice-President, Chief Human Resources Officer. In the position, he was responsible for a global HR team of over 600. He had served the company since 2009. Prior to this, Mulot worked in a HR leadership capacity at clothing firm Levi Strauss from 2002 to 2008 and tech start-up Broadnet Europe from 2000 to 2002. Earlier in his career he also had tenures at GTECH Corporation, International Post Corporation and Chronopost.
“I am delighted to welcome these two highly talented leaders to our executive team; both Ivana and Régis will play pivotal roles in the next phase of Ipsen’s transformation,” commented Ipsen CEO David Meek. Ivana has a strong track record in corporate business development and will bring further expertise to drive our external innovation and partnering strategy. Régis is an experienced international HR leader who will bring his passion for talent and organisational innovation to help further shape our One Ipsen culture.
“I would also like to take this opportunity to recognise Christophe Jean for his many contributions to Ipsen as Executive Vice-President, Strategy and Business Development,” he added. “Since joining the company in 2002 Christophe has played a key role for Ipsen and we wish him a successful and fulfilling retirement.”
Related Content
Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …
AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …
Phase 3 trials support expanded use of Dysport for migraine prevention
Ipsen has reported positive topline results from its phase 3 BEOND clinical programme evaluating Dysport …
